(Q43155516)

English

Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China

scientific article published in January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

author name string

L Yuan-Xin

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

L Ning

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

L You-Sheng

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

N Xiao-Dong

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

L Ming

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

W Jian

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

L Jie-Shou

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

0 references

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

29-34

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Technical refinements in small bowel transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Small bowel transplantation: technical advances/updates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Improved rejection surveillance in intestinal transplant recipients with frequent use of zoom video endoscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Serum citrulline and rejection in small bowel transplantation: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Clinical intestinal transplantation: a decade of experience at a single center

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Pediatric intestinal transplantation: historical notes, principles and controversies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Clinical intestinal transplantation: new perspectives and immunologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Induction therapy for clinical intestinal transplantation: comparison of four different regimens

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Current results of intestinal transplantation. The International Intestinal Transplant Registry.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Alemtuzumab (Campath-1H): a systematic review in organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Tolerogenic immunosuppression for organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Campath-1H induction and the incidence of infectious complications in adult renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.12.028

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2009.12.028

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43155516&oldid=1982332017"